SIGNUP FOR NEWSLETTER

TSX: HSM     NASDAQ: HSDT

Call us: +1 877-564-0008

newsBanner

Menu

Stock Quote - HSM-T

*Delayed quote courtesy of Google.

Stock Quote - HSDT

*Delayed quote courtesy of Google.

2018 News Releases

Title Date
Helius Medical Technologies, Inc. Submits CE Mark Application for PoNS™ Device 12 Dec, 2018
Helius Medical Technologies, Inc. Announces Exercise of Underwriters’ Overallotment Option 11 Dec, 2018
Helius Medical Technologies, Inc. Announces Pricing of Public Offering of Class A Common Stock 15 Nov, 2018
Helius Medical Technologies, Inc. Announces Proposed Public Offering of Class A Common Stock 14 Nov, 2018
Helius Medical Technologies, Inc. Reports Third Quarter 2018 Financial Results 08 Nov, 2018
Helius Medical Technologies to Present at the 12th Annual Canaccord Medical Technologies & Diagnostics Forum 01 Nov, 2018
Helius Medical Technologies, Inc. Announces Second Partnership to Implement Clinical Experience Programs with PoNS™ Treatment in the United States 24 Oct, 2018
Helius Medical Technologies Receives Medical Device License Clearance from Health Canada for PoNS™ Device 22 Oct, 2018
Helius Medical Technologies to Release Third Quarter 2018 Financial Results on November 8, 2018 18 Oct, 2018
Helius Medical Technologies and HealthTech Connex Announce Alliance to Build Canadian Commercial Infrastructure 02 Oct, 2018
Helius Medical Technologies Submits Medical Device License Application to Health Canada for PoNS™ Device 27 Sep, 2018
Helius Medical Technologies to Participate in Three Upcoming Conferences in October 24 Sep, 2018
Helius Announces First Partnership to Implement Clinical Experience Programs With the Investigational PoNS™ Therapy in the United States 19 Sep, 2018
Helius Medical Technologies Submits Request for FDA 510(k) Clearance of the PoNS™ Device 04 Sep, 2018
Helius Medical Technologies to Participate in the 20th Annual Global Investment Conference Sponsored by Rodman & Renshaw and H.C. Wainwright & Co. 04 Sep, 2018
Helius Medical Technologies, Inc. Announces Results of Matters Submitted for Vote at 2018 Annual Shareholder Meeting 23 Jul, 2018
Helius Medical Technologies, Inc. Names Jennifer Laux as Chief Commercialization Officer 12 Jul, 2018
Helius Medical Technologies, Inc. Announces MRI Confirmatory Evidence of Neuroplastic Change after Investigational PoNS™ Treatment Presented at the 2018 Joint Annual Meeting ISMRM – ESMRMB in Paris, France 28 Jun, 2018
Helius Medical Technologies, Inc. Joins Russell 3000® Index, Russell 2000® Index and Russell Microcap® Index 25 Jun, 2018
Helius Medical Technologies, Inc. Provides Update on its Anticipated Submission for FDA Clearance of the PoNS™ Device 18 Jun, 2018
Helius Medical Technologies, Inc. to Ring the Nasdaq Closing Bell on June 5th 04 Jun, 2018
Helius Medical Technologies, Inc. Announces Uplisting to Nasdaq and Pricing of Public Offering of Class A Common Stock and Warrants 11 Apr, 2018
Helius Medical Technologies, Inc. Announces Proposed Public Offering of Class A Common Stock and Warrants 03 Apr, 2018
Helius Medical Technologies and US Army Research Laboratory Launch Additional PoNS® Research 24 Jan, 2018
Helius Medical Technologies Completes Reverse Split of its Class A Common Stock 22 Jan, 2018
Helius Medical Technologies and HealthTech Connex Announce EEG Study Showing Stimulation by the Investigational PoNS® Device Impacts Brain Activity 07 Jan, 2018
Helius Medical Technologies Selects Key Tronic Corporation as its Commercial Contract Manufacturing Partner 05 Jan, 2018
Helius Medical Technologies Announces Planned Five-for-One Reverse Stock Split 03 Jan, 2018